---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-006675"
form_type: "8-K"
ticker: "CVRX"
cik: "0001235912"
company_name: "CVRx, Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T17:47:13.089336+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CVRx Q4 revenue $11.3M (+58% YoY); CEO Nadim Yared to retire; FY23 rev $39.3M (+75%)

## Summary
- Q4 revenue $11.3M (+58% YoY); US HF revenue $10.2M (+70% YoY).
- FY23 revenue $39.3M (+75% YoY); net loss $41.2M ($1.99/share); cash $90.6M.
- Active implanting centers 178 at year-end, up from 106 in prior year.
- CEO Nadim Yared announces retirement; board to conduct succession search; Yared stays until successor appointed.
- FDA approved expanded Barostim labeling; CMS increased outpatient payment to ~$45,000; market opportunity updated to $2.2B annually.

## SEC filing metadata
- accession: 0001104659-24-006675
- form_type: 8-K
- ticker: CVRX
- cik: 0001235912
- company_name: CVRx, Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/0001104659-24-006675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/tm244110d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-006675
- JSON: https://secwatch.observer/filing/0001104659-24-006675.json
- Plain text: https://secwatch.observer/filing/0001104659-24-006675.txt

## Key facts
- Earnings Releases
  CVRx, Inc. updated its the quarter and year ended December 31, 2023 guidance (reaffirmed).
  - Period: the quarter and year ended December 31, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On January 25, 2024, CVRx, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/0001104659-24-006675-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.